Table 2.
Cox regression analysis of the associations between AISI and cardiovascular mortality.
| Model1 | Model2 | Model3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95%CI | P-value | HR | 95%CI | P-value | HR | 95%CI | P-value | |
| Cardiovascular mortality | |||||||||
| Group1 | ref | ref | ref | ||||||
| Group2 | 1.02 | 0.82–1.26 | 0.878 | 1.03 | 0.85–1.25 | 0.761 | 1.12 | 0.88–1.43 | 0.362 |
| Group3 | 1.04 | 0.80–1.34 | 0.770 | 1.09 | 0.85–1.39 | 0.501 | 1.23 | 0.89–1.69 | 0.205 |
| Group4 | 1.68 | 1.34–2.11 | <0.001 | 1.75 | 1.39–2.19 | <0.001 | 1.91 | 1.42–2.58 | <0.001 |
Model 1: No adjusted.
Model 2: Adjusted by age, gender.
Model 3: Adjusted by age, gender, race,BMI, smoking, drinking, DM, CHD, CKD, CHF, Cr, drug, SBP.
BMI, body mass index; DM, diabetes mellitus; CHD, coronary heart disease; CKD, chronic kidney disease; CHF, congestive heart failure; Cr, creatinine; SBP, systolic blood pressure.